Corrigendum to "Telomere dysfunction and stem cell ageing" [Biochimie 90 (1) (2008) 24-32] (DOI:10.1016/j.biochi.2007.09.006);Telomere dysfunction and stem cell ageing

Biochimie

Volumn 90, Issue 1, 2008, Pages 24-32

  Ju, Zhenyu ^a,b   Rudolph, Lenhard ^a  

^a UNIVERSITY OF ULM   (Germany)

^b INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

Author keywords

Ageing; Stem cell; Telomere

Indexed keywords

ATM PROTEIN; PROTEIN; PROTEIN P16; PROTEIN P16INK4A; PROTEIN P19; PROTEIN P19ARF; PROTEIN P21; TRANSFORMATION RELATED PROTEIN P53; UNCLASSIFIED DRUG;

CELL AGING; CELL CYCLE ARREST; CELL DEATH; CELL FUNCTION; CHROMOSOME SIZE; DNA DAMAGE; HUMAN; NONHUMAN; REVIEW; SOMATIC CELL; STEM CELL; TELOMERE;

EID: 36749006617     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2008.01.007     Document Type: Erratum

References (121)

1. Blackburn E.H. Structure and function of telomeres. Nature 350 (1991) 569-573
2. Blackburn E.H. Switching and signaling at the telomere. Cell 106 (2001) 661-673
3. Harley C.B., Futcher A.B., and Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 345 (1990) 458-460
4. Shay J.W., and Wright W.E. Hayflick, his limit and cellular ageing. Nat. Rev. Mol. Cell Biol. 1 (2000) 72
5. Sfeir A.J., Chai W., Shay J.W., and Wright W.E. Telomere-end processing the terminal nucleotides of human chromosomes. Mol. Cell 18 1 (2005 Apr 1) 131-138
6. von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 27 7 (2002) 339-344
7. Allsopp R.C., Vaziri H., Patterson C., Goldstein S., Younglai E.V., Futcher A.B., Greider C.W., and Harley C.B. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 89 21 (1992) 10114-10118
8. Wright W.E., and Shay J.W. The two-stage mechanism controlling cellular senescence and immortalization. Exp. Gerontol. 27 (1992) 383-389
9. Bodnar A.G., Ouellette M., Frolkis M., Holt S.E., Chiu C.P., Morin G.B., Harley C.B., Shay J.W., Lichtsteiner S., and Wright W.E. Extension of life-span by introduction of telomerase into normal human cells. Science 279 (1998) 349-352
10. Zhu J., Wang H., Bishop J.M., and Blackburn E.H. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc. Natl. Acad. Sci. U.S.A. 96 7 (1999) 3723-3728
11. Broccoli D., Young J.W., and de Lange T. Telomerase activity in normal and malignant hematopoietic cells. Proc. Natl. Acad. Sci. U.S.A. 92 20 (1995) 9082-9086
12. Yasui W., Tahara E., Tahara H., Fujimoto J., Naka K., Nakayama J., Ishikawa F., Ide T., and Tahara E. Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach. Jpn. J. Cancer Res. 90 6 (1999) 589-595
13. Morrison S.J., Prowse K.R., Ho P., and Weissman I.L. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 5 3 (1996) 207-216
14. Vaziri H., Dragowska W., Allsopp R.C., Thomas T.E., Harley C.B., and Lansdorp P.M. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc. Natl. Acad. Sci. U.S.A. 91 21 (1994) 9857-9860
15. Engelhardt M., Kumar R., Albanell J., Pettengell R., Han W., and Moore M.A. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 90 1 (1997) 182-193
16. Wynn R.F., Cross M.A., Hatton C., Will A.M., Lashford L.S., Dexter T.M., and Testa N.G. Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. Lancet 17 351 (1998) 178-181
17. Flores I., Cayuela M.L., and Blasco M.A. Effects of telomerase and telomere length on epidermal stem cell behavior. Science 309 5738 (2005) 1253-1256
18. Sarin K.Y., Cheung P., Gilison D., Lee E., Tennen R.I., Wang E., Artandi M.K., Oro A.E., and Artandi S.E. Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436 7053 (2005) 1048-1052
19. Djojosubroto M.W., Choi Y.S., Lee H.W., and Rudolph K.L. Telomeres and telomerase in ageing, regeneration and cancer. Mol. Cell 15 (2003) 164-175
20. Fuster J.J., and Andres V. Telomere biology and cardiovascular disease. Circ. Res. 99 11 (2006 Nov 24) 1167-1180
21. Wiemann S.U., Satyanarayana A., Tsahuridu M., Tillmann H.L., Zender L., Klempnauer J., Flemming P., Franco S., Blasco M.A., Manns M.P., and Rudolph K.L. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J 16 9 (2002) 935-942
22. O'Sullivan J.N., Bronner M.P., Brentnall T.A., Finley J.C., Shen W.T., Emerson S., Emond M.J., Gollahon K.A., Moskovitz A.H., Crispin D.A., Potter J.D., and Rabinovitch P.S. Chromosomal instability in ulcerative colitis is related to telomere shortening. Nat. Genet. 32 2 (2002) 280-284
23. Feng Y.R., Biggar R.J., Gee D., Norwood D., Zeichner S.L., and Dimitrov D.S. Long-term telomere dynamics: modest increase of cell turnover in HIV-infected individuals followed for up to 14 years. Pathobiology 67 1 (1999) 34-38
24. Ball S.E., Gibson F.M., Rizzo S., Tooze J.A., Marsh J.C., and Gordon-Smith E.C. Progressive telomere shortening in aplastic anemia. Blood 91 10 (1998) 3582-3592
25. Leteurtre F., Li X., Guardiola P., Le Roux G., Sergere J.C., Richard P., Carosella E.D., and Gluckman E. Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. Br. J. Haematol. 105 4 (1999) 883-893
26. Panossian L.A., Porter V.R., Valenzuela H.F., Zhu X., Reback E., Masterman D., Cummings J.L., and Effros R.B. Telomere shortening in T cells correlates with Alzheimer's disease status. Neurobiol. Ageing 24 1 (2003) 77-84
27. Cawthon R.M., Smith K.R., O'Brien E., Sivatchenko A., and Kerber R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361 (2003) 393-395
28. Martin-Ruiz C.M., Gussekloo J., van Heemst D., von Zglinicki T., and Westendorp R.G. Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: a population-based study. Ageing Cell 4 6 (2005) 287-290
29. Vulliamy T., Marrone A., Goldman F., Dearlove A., Bessler M., Mason P.J., and Dokal I. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413 (2001) 432-435
30. Vulliamy T., Marrone A., Szydlo R., Walne A., Mason P.J., and Dokal I. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat. Genet. 36 (2004) 447-449
31. Armanios M.Y., Chen J.J., Cogan J.D., Alder J.K., Ingersoll R.G., Markin C., Lawson W.E., Xie M., Vulto I., Phillips III J.A., Lansdorp P.M., Greider C.W., and Loyd J.E. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 356 13 (2007) 1317-1326
32. Tsakiri K.D., Cronkhite J.T., Kuan P.J., Xing C., Raghu G., Weissler J.C., Rosenblatt R.L., Shay J.W., and Garcia C.K. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc. Natl. Acad. Sci. U.S.A. 104 18 (2007) 7552-7557
33. Vulliamy T., Marrone A., Dokal I., and Mason P.J. Association between aplastic anaemia and mutations in telomerase RNA. Lancet 359 (2002) 2168-2170
34. Yamaguchi H., Calado R.T., Ly H., Kajigaya S., Baerlocher G.M., Chanock S.J., Lansdorp P.M., and Young N.S. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. N. Engl. J. Med. 352 (2005) 1413-1424
35. Schlessinger D., and Van Zant G. Does functional depletion of stem cells drive ageing?. Mech. Ageing Dev. 122 (2001) 1537-1554
36. Van Zant G., and Liang Y. The role of stem cells in aging. Exp. Hematol. 31 8 (2003 Aug) 659-672
37. Harrison D.E., and Astle C.M. Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure. J. Exp. Med. 156 (1982) 1767-1779
38. Allsopp R.C., Cheshier S., and Weissman I.L. Telomere shortening accompanies increased cell cycle activity during serial transplantation of hematopoietic stem cells. J. Exp. Med. 193 8 (2001) 917-924
39. Allsopp R.C., Morin G.B., DePinho R., Harley C.B., and Weissman I.L. Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation. Blood 102 2 (2003) 517-520
40. Allsopp R.C., Morin G.B., Horner J.W., DePinho R., Harley C.B., and Weissman I.L. Effect of TERT over-expression on the long-term transplantation capacity of hematopoietic stem cells. Nat. Med. 9 4 (2003) 369-371
41. Ito K., Hirao A., Arai F., Takubo K., Matsuoka S., Miyamoto K., Ohmura M., Naka K., Hosokawa K., Ikeda Y., and Suda T. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med. 12 (2006) 446-451
42. Krishnamurthy J., Ramsey M.R., Ligon K.L., Torrice C., Koh A., Bonner-Weir S., and Sharpless N.E. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature 443 (2006) 453-457
43. Serrano M., Lin A.W., McCurrach M.E., Beach D., and Lowe S.W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 5 (1997) 593-602
44. Di Micco R., Fumagalli M., Cicalese A., Piccinin S., Gasparini P., Luise C., Schurra C., Garre' M., Nuciforo P.G., Bensimon A., Maestro R., Pelicci P.G., and d'Adda di Fagagna F. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444 7119 (2006) 638-642
45. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., and Greider C.W. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91 1 (1997) 25-34
46. Prowse K.R., and Greider C.W. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. U.S.A. 92 11 (1995) 4818-4822
47. Lee H.W., Blasco M.A., Gottlieb G.J., Horner J.W., Greider C.W., and DePinho R.A. Essential role of mouse telomerase in highly proliferative organs. Nature 392 (1998) 569-574
48. Rudolph K.L., Chang S., Lee H.W., Blasco M., Gottlieb G.J., Greider C., and DePinho R.A. Longevity, stress response, and cancer in ageing telomerase-deficient mice. Cell 96 (1999) 701-712
49. Herrera E., Samper E., Martin-Caballero J., Flores J.M., Lee H.W., and Blasco M.A. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J 18 11 (1999) 2950-2960
50. Choudhury A.R., Ju Z., Djojosubroto M.W., Schienke A., Lechel A., Schaetzlein S., Jiang H., Stepczynska A., Wang C., Buer J., Lee H.W., von Zglinicki T., Ganser A., Schirmacher P., Nakauchi H., and Rudolph K.L. Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat. Genet. 39 (2007) 99-105
51. Samper E., Fernandez P., Eguia R., Martin-Rivera L., Bernad A., Blasco M.A., and Aracil M. Long-term repopulating ability of telomerase-deficient murine hematopoietic stem cells. Blood 99 8 (2002) 2767-2775
52. Ferron S., Mira H., Franco S., Cano-Jaimez M., Bellmunt E., Ramirez C., Farinas I., and Blasco M.A. Telomere shortening and chromosomal instability abrogates proliferation of adult but not embryonic neural stem cells. Development 131 16 (2004) 4059-4070
53. Ju Z., Jiang H., Jaworski M., Gompf A., Rathinam C., Klein C., Trumpp A., and Rudolph K.L. Telomere dysfunction induces environmental defects limiting hematopoietic stem cell function and engraftment. Nat. Med. 13 (2007) 742-747
54. Hong Y., and Stambrook P.J. Restoration of an absent G1 arrest and protection from apoptosis in embryonic stem cells after ionizing radiation. Proc. Natl. Acad. Sci. U.S.A. 101 40 (2004) 14443-14448
55. Hemann M.T., Rudolph K.L., Strong M.A., DePinho R.A., Chin L., and Greider C.W. Telomere dysfunction triggers developmentally regulated germ cell apoptosis. Mol. Biol. Cell 12 (2001) 2023-2030
56. Satyanarayana A., Wiemann S.U., Buer J., Lauber J., Dittmar K.E., Wustefeld T., Blasco M.A., Manns M.P., and Rudolph K.L. Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. EMBO J 22 15 (2003) 4003-4013
57. d'Adda di Fagagna F., Reaper P.M., Clay-Farrace L., Fiegler H., Carr P., Von Zglinicki T., Saretzki G., Carter N.P., and Jackson S.P. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426 (2003) 194-198
58. Chin L., Artandj S.E., Shen Q., Tam A., Lee S.L., Gottlieb G.J., Greider C.W., and DePinho R.A. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97 4 (1999) 527-538
59. Herbig U., Jobling W.A., Chen B., Chen D.J., and Sedivy J.M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21CIP1, but Not p16INK4a. Mol. Cell 14 4 (2004) 501-513
60. Wong K.K., Maser R.S., Bachoo R.M., Menon J., Carrasco D.R., Gu Y., Alt F.W., and DePinho R.A. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421 (2003) 643-648
61. Khoo C.M., Carrasco D.R., Bosenberg M.W., Paik J.H., and Depinho R.A. Ink4a/Arf tumor suppressor does not modulate the degenerative conditions or tumor spectrum of the telomerase-deficient mouse. Proc. Natl. Acad. Sci. U.S.A. 104 10 (2007) 3931-3936
62. Schaetzlein S., Kodandaramireddy N.R., Ju Z., Lechel A., Stepzynska A., Lilli D.R., Clark A.B., Rudolph C., Wei K., Schlegelberger B., Schirmacher P., Kunkel T.A., Greenberg R.A., Edelmann W., and Rudolph K.L. Exonuclease-1 deletion impairs DNA damage signaling and prolongs lifespan of telomere-dysfunctional mice. Cell 130 (2007) 863-877
63. McKinnon P.J. ATM and ataxia telangiectasia. EMBO Rep 5 8 (2004) 772-776
64. Takai H., Smogorzewska A., and de Lange T. DNA damage foci at dysfunctional telomeres. Curr. Biol. 13 17 (2003) 1549-1556
65. Vaziri H., West M.D., Allsopp R.C., Davison T.S., Wu Y.S., Arrowsmith C.H., Poirier G.G., and Benchimol S. ATM-dependent telomere loss in ageing human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. EMBO J 16 19 (1997) 6018-6033
66. Hande M.P., Balajee A.S., Tchirkov A., Wynshaw-Boris A., and Lansdorp P.M. Extra-chromosomal telomeric DNA in cells from Atm-/- mice and patients with ataxia-telangiectasia. Hum. Mol. Genet. 10 (2001) 519-528
67. Greenwell P.W., Kronmal S.L., Porter S.E., Gassbenhuber J., Obermaier B., and Petes T.D. TEL1, a gene involved in controlling telomere length in S. cerevisiae, is homologous to the human ataxia telangiectasia gene. Cell 82 (1995) 823-829
68. Naito T., Matsuura A., and Ishikawa F. Circular chromosome formation in a fission yeast mutant defective in two ATM homologues. Nat. Genet. 20 (1998) 203-206
69. Greenberg R.A., Chin L., Femino A., Lee K.H., Gottlieb G.J., Singer R.H., Greider C.W., and DePinho R.A. Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell 97 4 (1999) 515-525
70. Rudolph K.L., Millard M., Bosenberg M.W., and DePinho R.A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet. 28 (2001) 155-159
71. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I., Nomiyama K., Hosokawa K., Sakurada K., Nakagata N., Ikeda Y., Mak T.W., and Suda T.W. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 431 (2004) 997-1002
72. Hara E., Tsurui H., Shinozaki A., Nakada S., and Oda K. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem. Biophys. Res. Commun. 179 1 (1991) 528-534
73. Bond J.A., Wyllie F.S., and Wynford-Thomas D. Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene 9 7 (1994) 1885-1889
74. Lechel A., Satyanarayana A., Ju Z., Plentz R.R., Schaetzlein S., Rudolph C., Wilkens L., Wiemann S.U., Saretzki G., Malek N.P., Manns M.P., Buer J., and Rudolph K.L. The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo. EMBO Rep 6 3 (2005) 275-281
75. Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., and DePinho R.A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406 6796 (2000) 641-645
76. Londono-Vallejo J.A. Telomere instability and cancer. Biochimie (2007) (Epub ahead of print).
77. Tyner S.D., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., Lu X., Soron G., Cooper B., Brayton C., Hee Park S., Thompson T., Karsenty G., Bradley A., and Donehower L.A. p53 mutant mice that display early ageing-associated phenotypes. Nature 415 (2002) 45-53
78. Dumble M., Moore L., Chambers S.M., Geiger H., Van Zant G., Goodell M.A., and Donehower L.A. The impact of altered p53 dosage on hematopoietic stem cell dynamics during ageing. Blood 109 4 (2007) 1736-1742
79. Garcia-Cao I., Garcia-Cao M., Martin-Caballero J., Criado L.M., Klatt P., Flores J.M., Weill J.C., Blasco M.A., and Serrano M. 'Super p53' mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J 21 (2002) 6225-6235
80. Garcia-Cao I., Garcia-Cao M., Tomas-Loba A., Martin-Caballero J., Flores J.M., Klatt P., Blasco M.A., and Serrano M. Increased p53 activity does not accelerate telomere-driven ageing. EMBO Rep 7 5 (2006) 546-552
81. Matheu A., Maraver A., Klatt P., Flores I., Garcia-Cao I., Borras C., Flores J.M., Vina J., Blasco M.A., and Serrano M. Delayed ageing through damage protection by the Arf/p53 pathway. Nature 448 7151 (2007) 375-379
82. El-Diery W.S., Harper J.W., O'Connor P.M., Velculescu V.E., Canman C.E., Jackman J., Pitenpol J.A., Burrell M., Hill D.E., and Wang Y. WAF1, a potential mediator of p53 tumour suppression. Cell 75 (1993) 817-825
83. Brown J.P., Wei W., and Sedivy J.M. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277 5327 (1997) 831-834
84. Xue W., Zender L., Miething C., Dickins R.A., Hernando E., Krizhanovsky V., Cordon-Cardo C., and Lowe S.W. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 7128 (2007) 656-660
85. Cheng T., Rodrigues N., Shen H., Yang Y., Dombkowski D., Sykes M., and Scadden D.T. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 287 (2000) 1804-1808
86. Qiu J., Takagi Y., Harada J., Rodrigues N., Moskowitz M.A., Scadden D.T., and Cheng T. Regenerative response in ischemic brain restricted by p21cip1/waf1. J. Exp. Med. 199 7 (2004) 937-945
87. Ju Z., Choudhury A.R., and Rudolph K.L. A dual role of p21 in stem cell ageing. Ann. NY Acad. Sci. 1100 (2007) 333-344
88. Krishnamurthy J., Torrice C., Ramsey M.R., Kovalev G.I., Al-Regaiey K., Su L., and Sharpless N.E. Ink4a/Arf expression is a biomarker of ageing. J. Clin. Invest. 114 9 (2004) 1299-3107
89. Janzen V., Forkert R., Fleming H.E., Saito Y., Waring M.T., Dombkowski D.M., Cheng T., DePinho R.A., Sharpless N.E., and Scadden D.T. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16(INK4a). Nature 443 (2006) 421-426
90. Molofsky A.V., Slutsky S.G., Joseph N.M., He S., Pardal R., Krishnamurthy J., Sharpless N.E., and Morrison S.J. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature 443 7110 (2006) 448-452
91. Alcorta D.A., Xiong Y., Phelps D., Hannon G., Beach D., and Barrett J.C. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 93 24 (1996) 13742-13747
92. Stein G.H., Drullinger L.F., Soulard A., and Dulic V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell. Biol. 19 3 (1999) 2109-2117
93. Jacobs J.J., and de Lange T. Significant role for p16INK4a in p53-independent telomere-directed senescence. Curr. Biol. 14 24 (2004) 2302-2308
94. Conboy I.M., Conboy M.J., Wagers A.J., Girma E.R., Weissman I.L., and Rando T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 433 (2005) 760-764
95. Nishimura E.K., Granter S.R., and Fisher D.E. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science 307 (2005) 720-724
96. Kim J.Y., Siegmund K.D., Tavare S., and Shibata D. Age-related human small intestine methylation: evidence for stem cell niches. BMC Med 3 (2005) 10
97. Ryu B.Y., Orwig K.E., Oatley J.M., Avarbock M.R., and Brinster R.L. Effects of ageing and niche microenvironment on spermatogonial stem cell self-renewal. Stem Cells 24 6 (2006) 1505-1511
98. Shefer G., Van de Mark D.P., Richardson J.B., and Yablonka-Reuveni Z. Satellite-cell pool size does matter: defining the myogenic potency of ageing skeletal muscle. Dev. Biol. 294 (2006) 50-66
99. Alvarez-Buylla A., and Lim D.A. For the long run: maintaining germinal niches in the adult brain. Neuron 41 5 (2004) 683-686
100. Miller A., and Van Zant G. Advances in hematopoietic stem cell research through mouse genetics. Curr. Opin. Hematol. 13 4 (2006) 209-215
101. Wilson A., and Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat. Rev. Immunol. 6 (2006) 93-106
102. Zhang J., Niu C., Ye L., Huang H., He X., Tong W.G., Ross J., Haug J., Johnson T., Feng J.Q., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425 (2003) 836-841
103. Ivanova N.B., Dimos J.T., Schaniel C., Hackney J.A., Moore K.A., and Lemischka I.R. A stem cell molecular signature. Science 298 (2002) 601-604
104. Kiel M.J., Yilmaz O.H., Iwashita T., Terhorst C., and Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121 (2005) 1109-1121
105. Visnjic D., Kalajzic Z., Rowe D.W., Katavic V., Lorenzo J., and Aguila H.L. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 103 (2004) 3258-3264
106. Zhu J., Garrett R., Jung Y., Zhang Y., Kim N., Wang J., Joe G.J., Hexner E., Choi Y., Taichman R., et al. Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells. Blood 109 (2007) 3706-3712
107. Keil M.J., Radice G.L., and Morrison S.J. Lack of evidence that hematopoietic stem cells depend on N-cadherin-mediated adhesion to osteoblasts for their maintenance. Cell Stem Cells 1 (2007) 204-217
108. Adams G.B., and Scadden D.T. The hematopoietic stem cell in its place. Nat. Immunol. 7 4 (2006) 333-337
109. Signer R.A., Montecino-Rodriguez E., Witte O.N., McLaughlin J., and Dorshkind K. Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia. Blood 110 (2007 Jun 6) 1831-1839
110. Hornsby P.J. Telomerization of mammalian cells and transplantation of telomerized cells in immunodeficient mice. Methods Mol. Biol. 240 (2004) 147-166
111. Shay J.W., and Wright W.E. The use of telomerized cells for tissue engineering. Nat. Biotechnol. 18 (2000) 22-23
112. Campisi J. Senescent cells, tumor suppression, and organismal ageing: good citizens, bad neighbors. Cell 120 4 (2005) 513-522
113. Maser R.S., Wong K.K., Sahin E., Xia H., Naylor M., Hedberg H.M., Artandi S.E., and DePinho R.A. DNA-dependent protein kinase catalytic subunit is not required for dysfunctional telomere fusion and checkpoint response in the telomerase-deficient mouse. Mol. Cell. Biol. 27 6 (2007) 2253-2265
114. Tlsty T.D., and Hein P.W. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr. Opin. Genet. Dev. 11 (2001) 54-59
115. Parrinello S., Coppe J., Krtolica A., and Campisi J. Stromal-epithelial interactions in ageing and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci. 118 (2005) 485-496
116. Krtolica A., Parrinello S., Lockett S., Desprez P., and Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and ageing. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12072-12077
117. Roninson I.B. Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett 179 (2002) 1-14
118. Li L., and Neaves W.B. Normal stem cells and cancer stem cells: the niche matters. Cancer Res 66 9 (2006) 4553-4557
119. Laconi S., Pani P., Pillai S., Pasciu D., Sarma D.S., and Laconi E. A growth-constrained environment drives tumor progression in vivo. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 7806-7811
120. Bilousova G., Marusyk A., Porter C.C., Cardiff R.D., and DeGregori J. Impaired DNA replication within progenitor cell pools promotes leukemogenesis. PLoS Biol 3 12 (2005) e401
121. El-Serag H.B., and Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132 7 (2007 Jun) 2557-2576